...
首页> 外文期刊>Annals of the American Thoracic Society >Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin
【24h】

Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin

机译:非晶药物的聚合物纳米核化改善稳定性,溶解,粉末流动和压缩性:壳聚糖涂层的吲哚美辛的情况

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

As a result of its higher molecular mobility, the surface of an amorphous drug can grow crystals much more rapidly than the bulk, causing poor stability and slow dissolution of drug products. We show that a nanocoating of chitosan (a pharmaceutically acceptable polymer) can be deposited on the surface of amorphous indomethacin by electrostatic deposition, leading to significant improvement of physical stability, wetting by aqueous media, dissolution rate, powder flow, and tabletability. The coating condition was chosen so that the positively charged polymer deposits on the negatively charged drug. Chitosan coating is superior to gelatin coating with respect to stability against crystallization and agglomeration of coated particles.
机译:由于其较高的分子迁移率,无定形药物的表面可以比散装更快地生长晶体,导致药物产品的稳定性差和缓慢溶解。 我们表明,通过静电沉积可以沉积壳聚糖(药学上可接受的聚合物)的纳米核化合物在无定形吲哚美辛的表面上,导致物理稳定性的显着提高,通过含水介质,溶解速率,粉末流动润湿。 选择涂层条件使得带正电荷的聚合物沉积在带负电荷的药物上。 壳聚糖涂层优于明胶涂层,相对于涂覆颗粒的结晶和附聚的稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号